Skip to content

A clinical trial to study the efficacy of Dashamooladi Shodhanbasti - Ayurveda panchakarma procedure - in patients with Artavakshaya i.e.Amenorrhoea,scanty and infrequent menstruation

Efficacy of Dashamooladi Shodhanbasti in Artavakshaya - A single blind randomized controlled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057947
Enrollment
100
Registered
2023-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N912- Amenorrhea, unspecified Health Condition 2: N915- Oligomenorrhea, unspecified Health Condition 3: N910- Primary amenorrhea Health Condition 4: N911- Secondary amenorrhea

Interventions

None listed

Sponsors

Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from menstrual irregularity as Artavakshaya or Rajaksheenata. 2. Patients having primary or secondary amenorrhoea as a symptom. 3.Patients with artavakshaya willing for conception. 2. Patients from 16 to 45 years of age.

Exclusion criteria

Exclusion criteria: 1. Patients having haemorrhagic disorders. 2. Patients with congenital & developmental defects of genital tract. 3. Patients with any new growth especially of reproductive system. 4. Patients with known HIV infection & other venereal diseases. 5. Patients having major systemic disorders like diabetes mellitus, tuberculosis,asthama, etc. 5. Pregnant & lactating womens. 7. Patients unfit for the treatment.

Design outcomes

Primary

MeasureTime frame
1. Rajasrava ( Discharge ) Duration 2. Rajasrava( Discharge ) Quantity in terms of pads 3. Intermenstrual period ( Interval between two cycles) 4. Pains during menses 5. Follicle Size 6. Endometrial thickness 7. Changes in Hormonal assays. 8. Improvement in haemoglobin percentage. 9. Changes in weight of the patient. Timepoint: 1. Rajasrava ( Discharge ) Duration -3 months 2. Rajasrava( Discharge ) Quantity in terms of pads & ml - 3 months 3. Intermenstrual period - 3 Months 4. Pains during menses - 3 Months 5. Follicle Size -3 Months 6. Endometrial thickness - 3 Months 7. Changes in Hormonal assays- 3 Months 8. Improvement in haemoglobin percentage - 3 Months 9. Changes in weight of the patient- 3 months

Secondary

MeasureTime frame
1.Rajasrava ( Discharge ) Duration 2. Rajasrava( Discharge ) Quantity in terms of pads 3. Intermenstrual period ( Interval between two cycles) 4. Pains during menses 5. Changes in weight of the patient.Timepoint: 1.Rajasrava ( Discharge ) Duration - 1 and 2 month 2. Rajasrava( Discharge ) Quantity in terms of pads 1 and 2 month 3. Intermenstrual period ( Interval between two cycles)-1 and 2 months 4. Pains during menses - 1 and 2 months 5. Changes in weight of the patient. 1 and 2 months

Countries

India

Contacts

Public ContactDr Salim Musa Mulla

Ayurvidya prasarak Mandals Ayurvedic Mahavidyalaya

sujatashrikantjagtap@gmail.com9820556568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026